01/30/2025
4:43 PM | Avalo Therapeutics, Inc. (Issuer)
Avalo Therapeutics (Issuer)
Sullivan Christopher Ryan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/30/2025
4:51 PM | Avalo Therapeutics, Inc. (Issuer)
Avalo Therapeutics (Issuer)
VARKI PAUL (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/30/2025
4:31 PM | Avalo Therapeutics, Inc. (Issuer)
Avalo Therapeutics (Issuer)
NEIL GARRY ARTHUR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/30/2025
4:20 PM | Avalo Therapeutics, Inc. (Issuer)
Avalo Therapeutics (Issuer)
Doyle Mittie (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/13/2025
6:07 AM | Avalo Therapeutics, Inc. (Filer)
Avalo Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/02/2025
6:04 AM | Avalo Therapeutics, Inc. (Filer)
Avalo Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/31/2024
3:13 PM | Affinity Asset Advisors, LLC (Filed by)
Avalo Therapeutics, Inc. (Subject)
Avalo Therapeutics (Subject)
| Form SCHEDULE 13G | |
12/05/2024
6:03 AM | Avalo Therapeutics, Inc. (Filer)
Avalo Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2024
5:23 PM | Avalo Therapeutics, Inc. (Subject)
Avalo Therapeutics (Subject)
ORBIMED ADVISORS LLC (Filed by)
| Form SC 13G | |
11/14/2024
4:21 PM | Almenoff June Sherie (Reporting)
Avalo Therapeutics, Inc. (Issuer)
Avalo Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/14/2024
11:05 AM | Allostery Investments LP (Filed by)
Avalo Therapeutics, Inc. (Subject)
Avalo Therapeutics (Subject)
| Form SC 13G/A | |
Get the Latest News and Ratings for AVTX and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Avalo Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
11/12/2024
6:30 AM | Avalo Therapeutics, Inc. (Filer)
Avalo Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/07/2024
4:00 PM | Avalo Therapeutics, Inc. (Subject)
Avalo Therapeutics (Subject)
Crutcher Patrick J (Filed by)
| Form SC 13G/A | |
11/07/2024
6:20 AM | Avalo Therapeutics, Inc. (Filer)
Avalo Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
11/07/2024
6:02 AM | Avalo Therapeutics, Inc. (Filer)
Avalo Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/07/2024
6:04 AM | Avalo Therapeutics, Inc. (Filer)
Avalo Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/07/2024
6:17 AM | Avalo Therapeutics, Inc. (Filer)
Avalo Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
10/08/2024
6:13 AM | Avalo Therapeutics, Inc. (Filer)
Avalo Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/07/2024
7:06 PM | Avalo Therapeutics, Inc. (Subject)
Avalo Therapeutics (Subject)
Ikarian Capital, LLC (Filed by)
| Form SC 13G | |
09/09/2024
6:22 AM | Avalo Therapeutics, Inc. (Filer)
Avalo Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/04/2024
6:01 AM | Avalo Therapeutics, Inc. (Filer)
Avalo Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/23/2024
3:34 PM | Avalo Therapeutics, Inc. (Subject)
Avalo Therapeutics (Subject)
BIOTECHNOLOGY VALUE FUND L P (Filed by)
| Form SC 13G | |
08/23/2024
3:16 PM | Avalo Therapeutics, Inc. (Subject)
Avalo Therapeutics (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
| Form SC 13G | |
08/14/2024
3:47 PM | Almenoff June Sherie (Reporting)
Avalo Therapeutics, Inc. (Issuer)
Avalo Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/14/2024
3:36 PM | Avalo Therapeutics, Inc. (Issuer)
Avalo Therapeutics (Issuer)
KANTOFF AARON (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/14/2024
3:27 PM | Avalo Therapeutics, Inc. (Issuer)
Avalo Therapeutics (Issuer)
Truex Samantha (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/12/2024
6:01 AM | Avalo Therapeutics, Inc. (Filer)
Avalo Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/12/2024
6:03 AM | Avalo Therapeutics, Inc. (Filer)
Avalo Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/05/2024
11:15 PM | Avalo Therapeutics, Inc. (Filer)
Avalo Therapeutics (Filer)
| Form EFFECT | |
07/16/2024
3:17 PM | Avalo Therapeutics, Inc. (Issuer)
Avalo Therapeutics (Issuer)
Doyle Mittie (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
07/16/2024
3:23 PM | Avalo Therapeutics, Inc. (Issuer)
Avalo Therapeutics (Issuer)
Doyle Mittie (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/16/2024
6:36 AM | Avalo Therapeutics, Inc. (Filer)
Avalo Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/11/2024
3:24 PM | Avalo Therapeutics, Inc. (Filer)
Avalo Therapeutics (Filer)
| Form S-3/A | |
07/09/2024
6:17 AM | Avalo Therapeutics, Inc. (Filer)
Avalo Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/27/2024
6:04 AM | Avalo Therapeutics, Inc. (Filer)
Avalo Therapeutics (Filer)
| Form ARS | |
06/27/2024
6:01 AM | Avalo Therapeutics, Inc. (Filer)
Avalo Therapeutics (Filer)
| Form DEF 14A | |
06/27/2024
6:03 AM | Avalo Therapeutics, Inc. (Filer)
Avalo Therapeutics (Filer)
| Form DEFA14A | |
06/24/2024
6:14 AM | Avalo Therapeutics, Inc. (Filer)
Avalo Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/07/2024
6:01 AM | Avalo Therapeutics, Inc. (Filer)
Avalo Therapeutics (Filer)
| Form PRE 14A | |
06/03/2024
6:20 AM | Avalo Therapeutics, Inc. (Filer)
Avalo Therapeutics (Filer)
| Form 8-K/A | |
05/13/2024
11:38 AM | Allostery Investments LP (Filed by)
Avalo Therapeutics, Inc. (Subject)
Avalo Therapeutics (Subject)
| Form SC 13G | |
Market down? Do this now. (Ad) During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now, history is repeating itself.
Here's the truth: Tariffs create uncertainty. Uncertainty drives investors to gold. And gold prices rise as a result. It's a cycle that's already beginning again—and it's your chance to profit.
Why wait? Greed isn't always a bad thing—especially when it comes to protecting and growing your wealth. The smartest investors are already moving their money into gold, and you should too. Download your Free 2025 Gold Guide Now |
05/13/2024
6:30 AM | Avalo Therapeutics, Inc. (Filer)
Avalo Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/13/2024
6:33 AM | Avalo Therapeutics, Inc. (Filer)
Avalo Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/23/2024
1:59 PM | Avalo Therapeutics, Inc. (Subject)
Avalo Therapeutics (Subject)
Emerald Bioventures, LLC (Filed by)
| Form SC 13G | |
04/09/2024
3:58 PM | Avalo Therapeutics, Inc. (Filer)
Avalo Therapeutics (Filer)
| Form D
Notice of Exempt Offering of Securities | |
03/28/2024
5:26 AM | Avalo Therapeutics, Inc. (Filer)
Avalo Therapeutics (Filer)
| Form DEFA14A | |
03/28/2024
5:08 AM | Avalo Therapeutics, Inc. (Filer)
Avalo Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
